Eton Pharmaceuticals to Participate at Leerink Partners Global Healthcare Conference

Got story updates? Submit your updates here. ›

Eton Pharmaceuticals, an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, announced that members of its executive leadership team will host one-on-one meetings at the Leerink Partners Global Healthcare Conference on Wednesday, March 11, 2026 in Miami, Florida.

Why it matters

Eton Pharmaceuticals is a growing pharmaceutical company with a focus on rare disease treatments, and its participation in high-profile industry conferences like the Leerink Partners event provides an opportunity to connect with investors and potential partners as it continues to expand its product portfolio.

The details

Eton Pharmaceuticals currently has eight commercial rare disease products and four additional product candidates in late-stage development. The one-on-one meetings at the Leerink Partners conference will allow the company's executives to discuss its progress and future plans with institutional investors.

• The Leerink Partners Global Healthcare Conference will take place on Wednesday, March 11, 2026 in Miami, Florida.

What’s next

Eton Pharmaceuticals executives will participate in one-on-one meetings with institutional investors at the Leerink Partners Global Healthcare Conference on March 11, 2026.